tenk.fyi

Inhibikase Therapeutics, Inc.

IKTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$0

100.0% YoY

Net Income

-$27.5M

44.6% YoY

EPS

$-1.16

63.3% YoY

Cash

$56.5M

514.1% YoY

FY 2024 · As of 2024-12-31